MAF/IgH Multiple Myeloma FISH Test
Comprehensive Genetic Analysis for Multiple Myeloma Detection
The MAF/IgH Multiple Myeloma Test represents a cutting-edge advancement in cancer diagnostics, specifically designed to detect critical genetic abnormalities associated with multiple myeloma. This specialized FISH (Fluorescence In Situ Hybridization) analysis provides invaluable insights into the genetic landscape of plasma cell disorders, enabling more precise diagnosis and personalized treatment strategies for patients battling this complex hematologic malignancy.
What Does the MAF/IgH Test Measure?
This sophisticated genetic test specifically targets and identifies translocations involving the MAF oncogene and the immunoglobulin heavy chain (IgH) locus. These chromosomal rearrangements are particularly significant because:
- Detects t(14;16) and t(14;20) translocations
- Identifies MAF gene family abnormalities
- Analyzes immunoglobulin heavy chain rearrangements
- Provides critical prognostic information
- Helps determine disease aggressiveness
Who Should Consider This Test?
The MAF/IgH Multiple Myeloma Test is recommended for individuals experiencing symptoms or clinical findings suggestive of plasma cell disorders, including:
- Patients with unexplained bone pain or fractures
- Individuals with persistent fatigue and weakness
- Those with recurrent infections and immune system concerns
- Patients showing abnormal protein levels in blood tests
- Individuals with kidney dysfunction of unknown origin
- Patients being evaluated for monoclonal gammopathy of undetermined significance (MGUS)
- Those requiring risk stratification for existing multiple myeloma diagnosis
Key Benefits of MAF/IgH Testing
Choosing the MAF/IgH Multiple Myeloma Test provides numerous advantages for both patients and healthcare providers:
- Accurate Prognostic Information: Identifies high-risk genetic features that influence treatment decisions
- Personalized Treatment Planning: Helps oncologists select the most effective therapeutic approaches
- Early Detection Capabilities: Can identify aggressive disease features before clinical progression
- Monitoring Disease Evolution: Tracks genetic changes over time for treatment adjustment
- Comprehensive Risk Assessment: Provides essential data for determining disease stage and prognosis
Understanding Your Test Results
Your MAF/IgH test results will provide critical information about your genetic profile:
- Positive Result: Indicates the presence of MAF/IgH translocations, suggesting high-risk multiple myeloma features that may require more aggressive treatment approaches
- Negative Result: Absence of these specific translocations, which may indicate standard-risk disease with potentially better prognosis
- Quantitative Analysis: The percentage of abnormal cells detected helps determine disease burden and monitor treatment response
It’s essential to discuss your results with your oncologist, who will interpret them in the context of your overall clinical picture, including other laboratory findings, imaging studies, and physical examination results.
Test Pricing and Details
| Test Component | Details |
|---|---|
| Test Name | MAF/IgH Multiple Myeloma FISH Test |
| Discount Price | $132 USD |
| Regular Price | $176 USD |
| Turnaround Time | 3-4 Days |
| Sample Type | Bone Marrow / Peripheral Blood |
| Test Components | Sodium Heparin Vacutainer (2ml) |
Nationwide Accessibility
GGC DNA maintains comprehensive testing facilities across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our nationwide network ensures that patients receive consistent, high-quality testing services regardless of their location.
Important Pre-Test Instructions
The MAF/IgH Multiple Myeloma Test requires a doctor’s prescription for most cases. Please note that prescription requirements do not apply to surgery and pregnancy cases or individuals planning international travel. Our experienced genetic counselors are available to answer any questions you may have about the testing process and requirements.
Take Control of Your Health Today
Don’t wait to get the critical genetic information you need for your multiple myeloma diagnosis and treatment planning. Our advanced FISH testing technology provides the precise genetic analysis required for optimal cancer care management.
Call or WhatsApp us now at +1(267) 388-9828 to schedule your MAF/IgH Multiple Myeloma Test and take the first step toward comprehensive genetic understanding of your condition.
Our dedicated patient care team is ready to assist you with scheduling, insurance questions, and any concerns you may have about the testing process. With rapid 3-4 day turnaround times and expert genetic analysis, GGC DNA provides the reliable, accurate testing you need for informed medical decisions.
